Anthracimycin
Anthracimycin is an aminoacyl-tRNA synthetase inhibitor. Anthracimycin exhibits in vitro antibacterial activity against methicillin-resistant Staphylococcus aureus strains, Bacillus anthracis, and Mycobacterium tuberculosis. Anthracimycin can be used in antibacterial research[1].
Product Specifications
CAS Number
1452849-94-3
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
[H][C@@]1([C@@H](C)/C=C\C=C\[C@@H](C)OC2=O)[C@@](C(CC([C@H]2C)=O)=O)([H])[C@]3([H])[C@]([H])(CC(C)=CC3)C=C1
Molecular Formula
C25H32O4
Molecular Weight
396.52
References & Citations
[1]Tian P, et al. Ten-step asymmetric total syntheses of potent antibiotics anthracimycin and anthracimycin B. Chem Sci. 2022 Oct 15;13 (43) :12776-12781.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680965-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470218-500 1x 500 µL
CD100 (Semaphorin-4D) (A8), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470716-500 1x 500 µL
Thymidylate Synthase (TS106 + TMS715), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC800827-100 1x 100 µL
Involucrin (IVRN/827), CF680 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470226-100 1x 100 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942038-500 1x 500 µL
Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (PMEL/2038), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details